Clinical Innovations Europe Limited
08849265
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 12/02/2020
CHIEF FINANCIAL OFFICER
BRITISH · UNITED STATES · Age 52
Persons with Significant Control
Investor Aktiebolag
Arsenalsgatan 8c, Se-103 32, Stockholm
Reg: 556013-8298 · Swedish Companies Register · Public Company
Notified 12/02/2020
Former PSCs
Mr Ken Reali
Ceased 12/02/2020
Mr Anthony Pritzker
Ceased 18/10/2017
Mr Steven Allen Cash
Ceased 12/02/2020
Mr Jay Robert Pritzker
Ceased 18/10/2017
Ms Janel Rose Fillinger
Ceased 30/10/2017
Mr Glenn Weatherley
Ceased 12/02/2020
Eqt Partners Inc
Ceased 12/02/2020
CompanyRankvs 54462+ SIC 86900 peers34
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£1
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—
Debtors
£10.1M
Tax at Year End(2023)
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 2.57 | +£0 |
| 2022 | 1.67 | — |
Derived from filed accounts. Not audited figures.